InsiderSignal.AI

InsiderSignal.ai

CGEM - Cullinan Therapeutics, Inc.

Insider Sale by Ahmed Nadim (Pres, CEO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Ahmed Nadim, serving as Pres, CEO at Cullinan Therapeutics, Inc. (CGEM), sold 13,515 shares at $14.47 per share, for a total transaction value of $195,562.00. Following this transaction, Ahmed Nadim now holds 390,803 shares of CGEM.

This sale represents a 3.00% decrease in Ahmed Nadim's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, February 24, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 25, 2026, 1 day after the trade was made.

Cullinan Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Ahmed Nadim

Pres, CEO

Nadim Ahmed is the President and Chief Executive Officer of Cullinan Therapeutics, Inc. (CGEM), a biopharmaceutical company developing modality-agnostic targeted oncology therapies and expanding into autoimmune diseases.[[1]](https://www.bio.org/events/bio-international-convention/speakers/1960128)[[2]](https://kendallsquare.org/meet-nadim-ahmed-president-and-ceo-at-cullinan-oncology/)[[3]](https://www.fiercebiotech.com/biotech/cullinan-ceo-recaps-bispecific-autoimmune-pivot-sets-efficacy-tone-lupus-readout) With over 25 years of leadership in oncology development and commercialization, his career includes serving as President, Hematology at Bristol Myers Squibb, where he oversaw product launches as a member of the Leadership Team, and President, Global Hematology & Oncology at Celgene, with prior roles at GSK in clinical development, medical affairs, commercial, and marketing.[[1]](https://www.bio.org/events/bio-international-convention/speakers/1960128)[[6]](https://medcitynews.com/author/nahmed/) Ahmed holds a Master of Science from Loughborough University, UK, and a Bachelor of Science from University College London, UK.[[1]](https://www.bio.org/events/bio-international-convention/speakers/1960128) He serves on the Board of Directors for Disc Medicine and Family Promise, a non-profit aiding homeless families, and received the 2023 Life Science Voice Top Industry Leader Award.[[1]](https://www.bio.org/events/bio-international-convention/speakers/1960128)[[4]](https://ir.discmedicine.com/news-releases/news-release-details/disc-medicine-appoints-nadim-ahmed-its-board-directors)

View full insider profile →

Trade Price

$14.47

Quantity

13,515

Total Value

$195,562.00

Shares Owned

390,803

Trade Date

Tuesday, February 24, 2026

3 days ago

SEC Filing Date

Wednesday, February 25, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Cullinan Therapeutics, Inc.

Company Overview

No company information available
View news mentioning CGEM

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4296757

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime